Imaging patterns in patients with newly diagnosed glioblastoma in England

被引:0
|
作者
Galldiks, Norbert [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
Lohmann, Philipp [2 ,3 ,8 ]
机构
[1] Univ Cologne, Dept Neurol, Fac Med, Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Cologne, Germany
[3] Res Ctr Juelich, Inst Neurosci & Med INM 3 4, Julich, Germany
[4] Univ Aachen, Ctr Integrated Oncol CIO, Cologne, Germany
[5] Univ Bonn, Ctr Integrated Oncol CIO, Cologne, Germany
[6] Univ Cologne, Ctr Integrated Oncol CIO, Cologne, Germany
[7] Univ Duesseldorf, Ctr Integrated Oncol CIO, Cologne, Germany
[8] Univ Cologne, Dept Stereotaxy & Funct Neurosurg, Fac Med, Cologne, Germany
关键词
D O I
10.1093/nop/npac059
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:461 / 462
页数:2
相关论文
共 50 条
  • [41] The Effect of Timing of Concurrent Chemoradiation in Patients With Newly Diagnosed Glioblastoma
    Han, Seunggu J.
    Rutledge, W. Caleb
    Molinaro, Annette M.
    Chang, Susan M.
    Clarke, Jennifer L.
    Prados, Michael D.
    Taylor, Jennie W.
    Berger, Mitchel S.
    Butowski, Nicholas A.
    NEUROSURGERY, 2015, 77 (02) : 248 - 253
  • [42] The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma
    Flechl, B.
    Sax, C.
    Ackerl, M.
    Crevenna, R.
    Woehrer, A.
    Hainfellner, J.
    Preusser, M.
    Widhalm, G.
    Kiesel, B.
    Lutgendorf-Caucig, C.
    Dieckmann, K.
    Steffal, C.
    Marosi, C.
    Hassler, M. R.
    RADIOTHERAPY AND ONCOLOGY, 2017, 125 (02) : 228 - 233
  • [43] The role of neoadjuvant clinical trials in patients with newly diagnosed glioblastoma
    Bazer, Danielle A.
    Grossman, Stuart A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Survival analysis in patients with newly diagnosed glioblastoma using pre- and postradiotherapy MR spectroscopic imaging
    Li, Yan
    Lupo, Janine M.
    Parvataneni, Rupa
    Lamborn, Kathleen R.
    Cha, Soonmee
    Chang, Susan M.
    Nelson, Sarah J.
    NEURO-ONCOLOGY, 2013, 15 (05) : 607 - 617
  • [45] Temporal muscle thickness as an independent prognostic imaging marker in newly diagnosed glioblastoma patients: A validation study
    Broen, Martinus P. G.
    Beckers, Rueben
    Willemsen, Anna C. H.
    Huijs, Sandra M. H.
    Pasmans, Raphael C. O. S.
    Eekers, Danielle B. P.
    Ackermans, Linda
    Beckervordersandforth, Jan
    van Raak, Elisabeth P. M.
    Verduin, Maikel
    Anten, Monique H. M. E.
    Hoeben, Ann
    Postma, Alida A.
    NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [46] Treatment of newly diagnosed glioblastoma multiforme
    Nieder, C
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3179 - 3180
  • [47] Treatment Options in Newly Diagnosed Glioblastoma
    Lee, Eudocia Q.
    Nayak, Lakshmi
    Wen, Patrick Y.
    Reardon, David A.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2013, 15 (03) : 281 - 288
  • [48] Bevacizumab for Newly Diagnosed Glioblastoma Reply
    Gilbert, Mark R.
    Sulman, Erik P.
    Mehta, Minesh P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (21): : 2048 - 2049
  • [49] Neuroradiological assessment of newly diagnosed glioblastoma
    Mukundan, Srini
    Holder, Chad
    Olson, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 89 (03) : 259 - 269
  • [50] Steroid management in newly diagnosed glioblastoma
    Mariel B. Deutsch
    Katherine S. Panageas
    Andrew B. Lassman
    Lisa M. DeAngelis
    Journal of Neuro-Oncology, 2013, 113 : 111 - 116